HomeCompareHRTT vs SBUX

HRTT vs SBUX: Dividend Comparison 2026

HRTT yields 285714.29% · SBUX yields 2.84%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 HRTT wins by $1428805773906827.50M in total portfolio value
10 years
HRTT
HRTT
● Live price
285714.29%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$1428805773906827.75M
Annual income
$837,995,958,409,897,800,000.00
Full HRTT calculator →
SBUX
SBUX
● Live price
2.84%
Share price
$86.72
Annual div
$2.46
5Y div CAGR
48.3%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$167.0K
Annual income
$71,136.45
Full SBUX calculator →

Portfolio growth — HRTT vs SBUX

📍 HRTT pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodHRTTSBUX
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, HRTT + SBUX cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
HRTT pays
SBUX pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

HRTT
Annual income on $10K today (after 15% tax)
$24,285,714.29/yr
After 10yr DRIP, annual income (after tax)
$712,296,564,648,413,100,000.00/yr
SBUX
Annual income on $10K today (after 15% tax)
$241.12/yr
After 10yr DRIP, annual income (after tax)
$60,465.98/yr
At 15% tax rate, HRTT beats the other by $712,296,564,648,413,100,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of HRTT + SBUX for your $10,000?

HRTT: 50%SBUX: 50%
100% SBUX50/50100% HRTT
Portfolio after 10yr
$714402886953414.00M
Annual income
$418,997,979,204,949,000,000.00/yr
Blended yield
58.65%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on SBUX right now

HRTT
No analyst data
Altman Z
-38.2
Piotroski
1/9
SBUX
Analyst Ratings
28
Buy
27
Hold
3
Sell
Consensus: Buy
Price Target
$104.00
+19.9% upside vs current
Range: $90.00 — $120.00
Altman Z
2.6
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

HRTT buys
0
SBUX buys
0
No recent congressional trades found for HRTT or SBUX in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricHRTTSBUX
Forward yield285714.29%2.84%
Annual dividend / share$2.00$2.46
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%48.3%
Portfolio after 10y$1428805773906827.75M$167.0K
Annual income after 10y$837,995,958,409,897,800,000.00$71,136.45
Total dividends collected$1380014861404866.75M$136.4K
Payment frequencyquarterlyquarterly
SectorStockConsumer Discretionary

Year-by-year: HRTT vs SBUX ($10,000, DRIP)

YearHRTT PortfolioHRTT Income/yrSBUX PortfolioSBUX Income/yrGap
1← crossover$14,296,414$14,285,714.29$11,121$420.68+$14.29MHRTT
2$9,558,964,911$9,543,667,747.47$12,548$648.40+$9558.95MHRTT
3$2,992,074,576,476$2,981,846,484,021.85$14,440$1,013.98+$2992074.56MHRTT
4$439,348,684,846,250$436,147,165,049,419.94$17,068$1,617.30+$439348684.83MHRTT
5$30,396,621,672,123,068$29,926,518,579,337,580.00$20,912$2,649.52+$30396621672.10MHRTT
6$1,000,040,954,618,524,400$967,516,569,429,352,800.00$26,875$4,499.29+$1000040954618.50MHRTT
7$15,944,363,321,622,526,000$14,874,319,500,180,705,000.00$36,771$8,014.12+$15944363321622.49MHRTT
8$127,879,086,422,155,850,000$110,818,617,668,019,750,000.00$54,542$15,197.11+$127879086422155.80MHRTT
9$552,158,706,071,897,000,000$415,328,083,600,190,200,000.00$89,602$31,242.49+$552158706071896.94MHRTT
10$1,428,805,773,906,827,800,000$837,995,958,409,897,800,000.00$167,011$71,136.45+$1428805773906827.50MHRTT

HRTT vs SBUX: Complete Analysis 2026

HRTTStock

Heart Tronics, Inc., a medical device company, engages in the research, development, and marketing of medical devices in the United States. Its medical devices are used to monitor and measure physiological signals in order to detect diseases that impact an individual's health. The company offers Fidelity 100 Monitor System, an integrated system in which its component Model 100 Patient Module collects, processes, and amplifies electrocardiogram (ECG) signals from that patient through a set of 10 electrodes that are wirelessly transmitted to the laptop computer. Its products in the development stage include Fidelity 350 Holter Monitor, an ambulatory Holter monitor that collects ECG data of arrhythmia and transient heart disease, while the patient carries out daily activities away from the physician's office or hospital. The company's products in the development stage also consist of Fidelity 200 Event Recording System/Heart Tempo Card, a non-prescription heart monitoring device, which is used as an early-detection device by patients who desire to monitor their condition. Its products also include Cardiac Vest, a lightweight, close-fitting vest or undergarment made of stretchable material in which the electrodes are stitched into the fabric; and Fidelity 400 Intracardiac Monitor that applies its proprietary physiological signal acquisition and amplification technology to read intracardiac signals procured from intracardiac catheter. The company was formerly known as Signalife, Inc. and changed its name to Heart Tronics, Inc. in November 2008. Heart Tronics, Inc. was incorporated in 1987 is headquartered in Studio City, California.

Full HRTT Calculator →

SBUXConsumer Discretionary

Starbucks Corporation, together with its subsidiaries, operates as a roaster, marketer, and retailer of specialty coffee worldwide. The company operates through three segments: North America, International, and Channel Development. Its stores offer coffee and tea beverages, roasted whole beans and ground coffees, single serve products, and ready-to-drink beverages; and various food products, such as pastries, breakfast sandwiches, and lunch items. The company also licenses its trademarks through licensed stores, and grocery and foodservice accounts. The company offers its products under the Starbucks, Teavana, Seattle's Best Coffee, Evolution Fresh, Ethos, Starbucks Reserve, and Princi brands. As of October 3, 2021, it operated 16,826 company-operated and licensed stores in North America; and 17,007 company-operated and licensed stores internationally. The company was founded in 1971 and is based in Seattle, Washington.

Full SBUX Calculator →
📬

Get this HRTT vs SBUX comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

HRTT vs SCHDHRTT vs JEPIHRTT vs OHRTT vs KOHRTT vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.